Mid Month Update

Hey everyone! Like I mentioned in the last post, the big news is that MoomooCA has set up a server for me, and it's open for all of you to join! It’s called Trader’s Tavern, and yes—the profile pic is my cat <3

In there, I’ll be sharing more in-depth stock analysis, including entry and target points, plus detailed descriptions of each stock. It’d be great if you all could join us there!

In the meantime, here’s our mid-month update on some stocks I’m keeping an eye on! Let’s aim for some solid profits! (Won't be providing Entry and Targets this time, but I have provided a small description of the company!)

Focuses on developing cancer treatments. Its leading prostate cancer drug is progressing well in clinical trials, with shares up approximately 350% this year

Known for modular sectional couches and beanbag chairs, Lovesac reported 37% net sales growth in its fiscal 2021, with shares rising 450% over the past 12 months

Capitalizing on the health and wellness trend with popular protein-based products

Develops voice-enabled AI software for various industries. The company is forecasted to grow its revenue by approximately 80% this year

Provides seaborne transportation of petroleum products and chemicals. Exhibits consistent earnings and dividend payouts, maintaining shareholder value

A real estate investment trust focusing on industrial properties. Demonstrates commitment through dividend hikes, reflecting stable cash flows and investor confidence

language-learning platform offering courses in multiple languages through its app and website, known for its gamified learning approach

Provides a B2B e-commerce platform for large parcel merchandise, facilitating transactions between manufacturers and resellers globally

Toy and consumer products company, producing a wide range of toys, electronics, and related products under various brand names

Leading frozen foods company in Europe, with brands like Birds Eye, Findus, and Iglo, offering a range of frozen meals and vegetables

Pharmaceutical company with a diverse portfolio, including treatments for diabetes, oncology, immunology, and neuroscience

Let's see if all these will go UP or DOWN.

Will be watching for the next 4 months!